Zotepine

This classification denotes a serotonin antagonist and dopamine antagonist with the molecular formula C18H18ClNOS, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier U29O83JAZW, chemically known as 2-chloro-11-(2-dimethylaminoethoxy)-dibenzo(b,f)thiepine but generally known as zotepine, which bears US NIH Compound Identifier 5736. European Medicines Agency schedules Zotepine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00191MIG. The term ZOTEPINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 31, No10, 1977, List 17). World Health Organization schedules zotepine in its Anatomical Therapeutic Chemical (ATC) Classification. ZOTEPINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule zotepine under HS 29349990 and SITC 51579. As of Q4 2014, ZOTEPINE remains the US FDA Preferred Term for this commodity. Zotepine bears US NLM identifiers UMLS ID C0078849 and NCI Concept Code C81096. SMILES: CLC1CC2C(=CC3C(SC2CC1)CCCC3)OCCN(C)C.